Flavoured Veterinary Medications Market - Segments, Dynamics, Size and Forecast (2015 - 2021)

Flavoured Veterinary Medications Market - Segments, Dynamics, Size and Forecast (2015 - 2021) Recently, Elanco Animal Health announced that the Interceptor Flavor Tablets (milbemycin oxime) would be back in the veterinary market. Interceptor Flavor Tablets protects against whipworms, roundworms and hookworms in dogs. They also prevent heartworms diseases in cats and kittens. Merck Animal Health announced the approval of BRAVECTO™ (four-lane) chewable tablets for dogs (112.5 mg, 250 mg, 500 mg, 1000 mg, 1400 mg). It quickly and effectively kills fleas and multiple tick species for 12 weeks in a single dose. Virbac Corporation announced an agreement with Eli Lilly and Company to acquire major U.S. veterinary products currently marketed by Novartis Animal Health.

More information